The impact of pharmacological thromboprophylaxis and disease-stage on postoperative bleeding following colorectal cancer surgery.
Hiroyuki OhtaToru MiyakeTomoharu ShimizuHiromichi SonodaTomoyuki UekiSachiko KaidaTsuyoshi YamaguchiHiroya IidaMasaji TaniPublished in: World journal of surgical oncology (2019)
Fondaparinux administration and early disease-stage CRC appeared to be risk factors for postoperative bleeding in patients with pharmacological thromboprophylaxis undergoing surgical treatment for CRC. Patients' hypercoagulative condition depending on disease progression of CRC might be related to the occurrence of postoperative bleeding following CRC surgery.
Keyphrases
- patients undergoing
- minimally invasive
- atrial fibrillation
- end stage renal disease
- coronary artery bypass
- venous thromboembolism
- ejection fraction
- newly diagnosed
- chronic kidney disease
- direct oral anticoagulants
- surgical site infection
- risk assessment
- peritoneal dialysis
- prognostic factors
- patient reported outcomes
- percutaneous coronary intervention
- acute coronary syndrome
- drug induced
- patient reported